Quest Diagnostics Inc
Research Quest Diagnostics Inc (DGX) on Bullrun: valuation model: 5.6% overvalued, market cap USD 26.90B, P/E 25.9, dividend yield 1.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDGX
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Valuation signal5.6% overvalued
- Market capUSD 26.90B
- P/E25.9
- Dividend yield1.4%
- Financial periodQ2 2026
- RevenueUSD 3.04B
- Net incomeUSD 320.00M
- Free cash flowUSD 459.00M
- Gross margin33.7%
Valuation Snapshot
Bullrun's latest valuation model marks Quest Diagnostics Inc as 5.6% overvalued; latest market cap is USD 26.90B; P/E is 25.9; dividend yield is 1.4%.
Peer valuation comparison
Latest P/E is 25.94x versus a Healthcare sector median of 24.46x (6.0% above).
Latest dividend yield is 1.36% versus a Healthcare sector median of 2.11% (35.5% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 11.04B | USD 992.00M | USD 1.36B | 33.2% | 8.75 | USD 420.00M | USD 5.67B | USD 7.17B |
| FY2024 | USD 9.87B | USD 871.00M | USD 909.00M | 32.9% | 7.69 | USD 549.00M | USD 6.22B | USD 6.78B |
| FY2023 | USD 9.25B | USD 854.00M | USD 864.00M | 33.0% | 7.49 | USD 686.00M | USD 4.71B | USD 6.31B |
| FY2022 | USD 9.88B | USD 946.00M | USD 1.31B | 34.7% | 7.97 | USD 315.00M | USD 3.98B | USD 5.89B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 26.90B | 25.9 | 1.4% | 3.32 |
| 2025 | 2025-12-31 | USD 19.13B | 19.8 | 1.8% | 3.15 |
| 2024 | 2024-12-31 | USD 16.69B | 19.6 | 2.0% | 2.96 |
| 2023 | 2023-12-29 | USD 15.50B | 20.7 | 2.0% | 2.79 |
| 2022 | 2022-12-30 | USD 17.82B | 15.4 | 1.7% | 2.6 |
| 2021 | 2021-12-31 | USD 20.59B | 11.1 | 1.4% | 2.42 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 3.32 USD, yield 1.4%.
| Year | Dividends/share |
|---|---|
| FY2025 | 3.15 USD |
| FY2024 | 2.96 USD |
| FY2023 | 2.79 USD |
| FY2022 | 2.6 USD |
About Quest Diagnostics Inc
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Quest Diagnostics Inc overvalued or undervalued?
Bullrun's valuation model currently marks Quest Diagnostics Inc as 5.6% overvalued.
What is Quest Diagnostics Inc's market cap?
Quest Diagnostics Inc's market capitalization is USD 26.90B.
What is Quest Diagnostics Inc's P/E ratio?
Quest Diagnostics Inc's price-to-earnings (P/E) ratio is 25.9.
Does Quest Diagnostics Inc pay a dividend?
Quest Diagnostics Inc has a dividend yield of 1.4%.
What does Quest Diagnostics Inc do?
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.